Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264M
Number of holders
48
Total 13F shares, excl. options
9.53M
Shares change
+5.03M
Total reported value, excl. options
$448M
Value change
+$237M
Number of buys
36
Number of sells
-5
Price
$47.03

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2020

49 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q3 2020.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.53M shares of 264M outstanding shares and own 3.6% of the company stock.
Largest 10 shareholders include HILLHOUSE CAPITAL ADVISORS, LTD. (1.5M shares), Avidity Partners Management LP (1.34M shares), Snow Lake Capital (HK) Ltd (1.19M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.18M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (827K shares), Artal Group S.A. (725K shares), Artisan Partners Limited Partnership (643K shares), ORBIMED ADVISORS LLC (606K shares), SPHERA FUNDS MANAGEMENT LTD. (182K shares), and MORGAN STANLEY (162K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.